A detailed history of Simplex Trading, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,248 shares of RPTX stock, worth $3,034. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,248
Previous 3,924 42.71%
Holding current value
$3,034
Previous $12,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$2.75 - $3.99 $4,609 - $6,687
-1,676 Reduced 42.71%
2,248 $7,000
Q2 2024

Jul 25, 2024

SELL
$3.02 - $4.7 $4,086 - $6,359
-1,353 Reduced 25.64%
3,924 $12,000
Q1 2024

Apr 25, 2024

SELL
$4.53 - $8.41 $23,900 - $44,371
-5,276 Reduced 50.0%
5,277 $24,000
Q4 2023

Feb 02, 2024

SELL
$3.22 - $11.79 $28,158 - $103,103
-8,745 Reduced 45.32%
10,553 $77,000
Q3 2023

Nov 01, 2023

BUY
$8.16 - $13.01 $111,147 - $177,209
13,621 Added 239.93%
19,298 $233,000
Q2 2023

Aug 04, 2023

BUY
$8.63 - $12.53 $40,491 - $58,790
4,692 Added 476.35%
5,677 $60,000
Q1 2023

Apr 27, 2023

SELL
$9.32 - $15.06 $54,167 - $87,528
-5,812 Reduced 85.51%
985 $9,000
Q4 2022

Feb 02, 2023

BUY
$12.5 - $18.13 $84,687 - $122,830
6,775 Added 30795.45%
6,797 $99,000
Q3 2022

Nov 04, 2022

SELL
$11.57 - $15.59 $15,017 - $20,235
-1,298 Reduced 98.33%
22 $0
Q2 2022

Aug 03, 2022

BUY
$8.45 - $14.84 $10,858 - $19,069
1,285 Added 3671.43%
1,320 $18,000
Q1 2022

May 02, 2022

SELL
$11.38 - $21.88 $3,015 - $5,798
-265 Reduced 88.33%
35 $0
Q4 2021

Feb 23, 2022

BUY
$19.66 - $28.11 $5,898 - $8,433
300 New
300 $6,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.